Press / Media
- 20 results
Search results
-
Clinical Trial: Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1)
29/09/21
2 items of Media coverage
Press/Media
-
VEINTIS™ the tissue-engineered vascular graft developed by Cells for Cells, wins the 2020 National Innovation Prize
12/11/20 → 13/11/20
2 items of Media coverage
Press/Media
-
Head Line: CELLS FOR CELLS S.A granted US Patent for "Device, platform, and assay for assessing cells"
10/09/20
1 item of Media coverage
Press/Media
-
Cells for Cells Obtains Patent for Device, Platform and Assay for Assessing Cells
9/09/20
1 item of Media coverage
Press/Media
-
US Patent Issued to CELLS FOR CELLS on Sept. 8 for "Device, platform, and assay for assessing cells" (Chilean Inventor)
9/09/20
1 item of Media coverage
Press/Media
-
Cells for Cells: US patent granted for bioinspired grafts. An accelerator for the transition from medical research to medical practice ?
23/06/20
1 item of Media coverage
Press/Media
-
Chilean company at the forefront of the global race to address the critical need for vascular graft.
22/06/20
1 item of Media coverage
Press/Media
-
-
A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1)
1/02/19
1 item of Media coverage
Press/Media
-
Clinical Trial: Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis
28/01/19
1 item of Media coverage
Press/Media
-
Osteoarthritis Stem Cell Therapy Success in Phase I and II Trials
11/01/19
1 item of Media coverage
Press/Media
-
WIPO PUBLISHES PATENT OF S. A CELLS FOR CELLS FOR "METHOD FOR PRODUCING MULTILAYERED COMPOSITES AND THEIR USES" (CHILEAN INVENTORS)
25/12/18
1 item of Media coverage
Press/Media
-
A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis
2/10/18
1 item of Media coverage
Press/Media
-
Head Line: European Patent Office granted patent to CELLS FOR CELLS S A [CL] titled as "DEVICE, PLATFORM, AND ASSAY FOR ASSESSING CELLS"
1/01/18
1 item of Media coverage
Press/Media
-
Tocilizumab linked with highest risk for neutropenia in comparison study that included abatacept, infliximab
21/04/17
1 item of Media coverage
Press/Media
-
Head Line: WIPO PUBLISHES PATENT OF CELLS FOR CELLS S.A TITLED AS "DEVICE, PLATFORM, AND ASSAY FOR ASSESSING CELLS"
15/10/16
2 items of Media coverage
Press/Media
-
Head Line: WIPO PUBLISHES PATENT OF CELLS FOR CELLS S.A TITLED AS "DEVICE, PLATFORM, AND ASSAY FOR ASSESSING CELLS"
26/08/16
1 item of Media coverage
Press/Media